JP2024543345A5 - - Google Patents
Info
- Publication number
- JP2024543345A5 JP2024543345A5 JP2024526836A JP2024526836A JP2024543345A5 JP 2024543345 A5 JP2024543345 A5 JP 2024543345A5 JP 2024526836 A JP2024526836 A JP 2024526836A JP 2024526836 A JP2024526836 A JP 2024526836A JP 2024543345 A5 JP2024543345 A5 JP 2024543345A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- week
- subject
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163280069P | 2021-11-16 | 2021-11-16 | |
| US63/280,069 | 2021-11-16 | ||
| US202263357240P | 2022-06-30 | 2022-06-30 | |
| US63/357,240 | 2022-06-30 | ||
| PCT/US2022/049969 WO2023091414A1 (en) | 2021-11-16 | 2022-11-15 | Compounds for treating mds-associated anemias and other conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543345A JP2024543345A (ja) | 2024-11-21 |
| JP2024543345A5 true JP2024543345A5 (cg-RX-API-DMAC7.html) | 2025-11-26 |
Family
ID=84887868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526836A Withdrawn JP2024543345A (ja) | 2021-11-16 | 2022-11-15 | Mds関連貧血及び他の状態を処置するための化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250108049A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433057A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024543345A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240107326A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022390088B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3236880A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024001431A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312679A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005852A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202329935A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023091414A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024238659A1 (en) * | 2023-05-15 | 2024-11-21 | Agios Pharmaceuticals, Inc. | Crystalline salts or amorphous forms of 2-((1h-pyrazol-3-yl)methyl)-6-((6-aminopyridin-2-yl)methyl)-4-methyl-4,6-dihydro -5h-thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one |
| WO2026076363A1 (en) | 2024-10-04 | 2026-04-09 | Agios Pharmaceuticals, Inc. | Compounds for treating mds-associated anemias and other conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20120693A1 (es) | 2009-06-29 | 2012-07-04 | Agios Pharmaceuticals Inc | Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2) |
| MX384883B (es) | 2015-06-11 | 2025-03-14 | Agios Pharmaceuticals Inc | Métodos para usar activadores de piruvato cinasa. |
| EP3668513B1 (en) | 2017-08-15 | 2021-11-10 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in treating blood disorders |
| KR102682430B1 (ko) | 2017-11-22 | 2024-07-08 | 아지오스 파마슈티컬스 아이엔씨. | N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의 결정 형태 |
| JP2022533227A (ja) | 2019-05-22 | 2022-07-21 | アジオス ファーマシューティカルズ, インコーポレイテッド | N-(4-(4-(シクロプロピルメチル)ピペラジン-1-カルボニル)フェニル)キノリン-8-スルホンアミドの結晶性塩形態 |
-
2022
- 2022-11-15 KR KR1020247019391A patent/KR20240107326A/ko not_active Withdrawn
- 2022-11-15 MX MX2024005852A patent/MX2024005852A/es unknown
- 2022-11-15 CA CA3236880A patent/CA3236880A1/en active Pending
- 2022-11-15 TW TW111143555A patent/TW202329935A/zh unknown
- 2022-11-15 EP EP22839539.8A patent/EP4433057A1/en active Pending
- 2022-11-15 US US18/711,090 patent/US20250108049A1/en active Pending
- 2022-11-15 WO PCT/US2022/049969 patent/WO2023091414A1/en not_active Ceased
- 2022-11-15 IL IL312679A patent/IL312679A/en unknown
- 2022-11-15 JP JP2024526836A patent/JP2024543345A/ja not_active Withdrawn
- 2022-11-15 AU AU2022390088A patent/AU2022390088B2/en active Active
-
2024
- 2024-05-14 CL CL2024001431A patent/CL2024001431A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1111414C (zh) | 镁盐或镁配合物的制药用途 | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2001520656A (ja) | 抗腫瘍剤としてのホルボールエステル類 | |
| JP2022519744A5 (cg-RX-API-DMAC7.html) | ||
| JP2022521233A5 (cg-RX-API-DMAC7.html) | ||
| JP2024536126A5 (cg-RX-API-DMAC7.html) | ||
| JP2018507260A5 (cg-RX-API-DMAC7.html) | ||
| CN113842449B (zh) | 枸杞糖肽在制备预防和/或治疗肌萎缩侧索硬化的药物中的应用 | |
| WO2018214860A1 (zh) | 治疗再生障碍性贫血的方法和药物组合物 | |
| JP2023553253A5 (cg-RX-API-DMAC7.html) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| TWI760306B (zh) | 供治療癌症之口服投予紫杉醇及P-gp抑制劑的治療性組合 | |
| JP2024545496A5 (cg-RX-API-DMAC7.html) | ||
| JPH08512311A (ja) | 慢性疲労症候群治療用ヒ素医薬 | |
| US20140296149A1 (en) | Compositions and Methods for the Treatment of Cardiac Surgery-Associated Acute Kidney Injury with Annexin A1 Peptide | |
| JP7505160B2 (ja) | ヒドロキシ尿素を含む炎症反応を阻害するための医薬組成物 | |
| JPWO2022265031A5 (cg-RX-API-DMAC7.html) | ||
| JP3253878B2 (ja) | 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法 | |
| JP2025505578A5 (cg-RX-API-DMAC7.html) | ||
| CN117224514B (zh) | 一种化合物、组合物及其在制备治疗心律失常的药物中的应用 | |
| EP3954374A1 (en) | Pharmaceutical combination of pimozide and methotrexate and use thereof | |
| US6355682B1 (en) | Treatment of acute renal failure by administration of N-acetylcysteine | |
| CN114887063A (zh) | Pacsin1在抑制瑞芬太尼诱发的痛觉过敏中的应用 | |
| JPS6260368B2 (cg-RX-API-DMAC7.html) | ||
| RU2811959C1 (ru) | Способ предоперационной коррекции анемии у больных колоректальным раком с метастазами в печень |